Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Information manipulation and historical revisionism: Russian disinformation and foreign interference through manipulated history-based narratives.
Arribas CM, Arcos R, Gértrudix M, Mikulski K, Hernández-Escayola P, Teodor M, Novăcescu E, Surdu I, Stoian V, García-Jiménez A. Arribas CM, et al. Among authors: arcos r. Open Res Eur. 2023 Jul 27;3:121. doi: 10.12688/openreseurope.16087.1. eCollection 2023. Open Res Eur. 2023. PMID: 37736288 Free PMC article.
A Public Health Research Agenda for Managing Infodemics: Methods and Results of the First WHO Infodemiology Conference.
Calleja N, AbdAllah A, Abad N, Ahmed N, Albarracin D, Altieri E, Anoko JN, Arcos R, Azlan AA, Bayer J, Bechmann A, Bezbaruah S, Briand SC, Brooks I, Bucci LM, Burzo S, Czerniak C, De Domenico M, Dunn AG, Ecker UKH, Espinosa L, Francois C, Gradon K, Gruzd A, Gülgün BS, Haydarov R, Hurley C, Astuti SI, Ishizumi A, Johnson N, Johnson Restrepo D, Kajimoto M, Koyuncu A, Kulkarni S, Lamichhane J, Lewis R, Mahajan A, Mandil A, McAweeney E, Messer M, Moy W, Ndumbi Ngamala P, Nguyen T, Nunn M, Omer SB, Pagliari C, Patel P, Phuong L, Prybylski D, Rashidian A, Rempel E, Rubinelli S, Sacco P, Schneider A, Shu K, Smith M, Sufehmi H, Tangcharoensathien V, Terry R, Thacker N, Trewinnard T, Turner S, Tworek H, Uakkas S, Vraga E, Wardle C, Wasserman H, Wilhelm E, Würz A, Yau B, Zhou L, Purnat TD. Calleja N, et al. Among authors: arcos r. JMIR Infodemiology. 2021 Sep 15;1(1):e30979. doi: 10.2196/30979. eCollection 2021 Jan-Dec. JMIR Infodemiology. 2021. PMID: 34604708 Free PMC article.
Diacylglycerol kinases in cancer.
Mérida I, Torres-Ayuso P, Ávila-Flores A, Arranz-Nicolás J, Andrada E, Tello-Lafoz M, Liébana R, Arcos R. Mérida I, et al. Among authors: arcos r. Adv Biol Regul. 2017 Jan;63:22-31. doi: 10.1016/j.jbior.2016.09.005. Epub 2016 Sep 23. Adv Biol Regul. 2017. PMID: 27697466 Review.
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer.
Patnaik A, Haluska P, Tolcher AW, Erlichman C, Papadopoulos KP, Lensing JL, Beeram M, Molina JR, Rasco DW, Arcos RR, Kelly CS, Wijayawardana SR, Zhang X, Stancato LF, Bell R, Shi P, Kulanthaivel P, Pitou C, Mulle LB, Farrington DL, Chan EM, Goetz MP. Patnaik A, et al. Among authors: arcos rr. Clin Cancer Res. 2016 Mar 1;22(5):1095-102. doi: 10.1158/1078-0432.CCR-15-1718. Epub 2015 Nov 18. Clin Cancer Res. 2016. PMID: 26581242 Clinical Trial.
12 results